Oxford Textbook of Heart Failure: Oxford Textbooks in Cardiology
Editat de Andrew L. Clark, Roy S. Gardner, Theresa A. McDonaghen Limba Engleză Hardback – 20 mai 2022
manage a patient with heart failure. In full colour throughout, containing over 300 illustrations, and supported by detailed referencing from the huge evidence base that has developed over the last two decades, the textbook also includes extensive chapters on common co-morbidities. The new edition has been completely updated in line
with new British and European Guidelines and contains new chapters on; Natriuretic Peptides and Novel Biomarkers in Heart Failure, The Future of Heart Failure, and Regenerative Therapies. Essential reading for consultant cardiologists and those in training, general physicians and those caring of the elderly, cardiothoracic surgeons, primary care doctors, pharmacists, and specialist nurses.
Preț: 1152.00 lei
Preț vechi: 1566.75 lei
-26% Nou
220.47€ • 229.01$ • 183.13£
Carte disponibilă
Livrare economică 31 decembrie 24 - 06 ianuarie 25
Livrare express 31 decembrie 24 - 04 ianuarie 25 pentru 446.05 lei
Specificații
ISBN-10: 019876622X
Pagini: 896
Dimensiuni: 228 x 280 x 38 mm
Greutate: 2.42 kg
Ediția:2
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Textbooks in Cardiology
Locul publicării:Oxford, United Kingdom
Descriere
Taking the reader from an understanding of the basic mechanisms of heart failure through to an appreciation of the complexities of heart failure management and the remarkable improvements possible with good treatment, the Oxford Textbook of Heart Failure 2e covers all aspects necessary to
manage a patient with heart failure.
In full colour throughout, containing over 300 illustrations, and supported by detailed referencing from the huge evidence base that has developed over the last two decades, the textbook also includes extensive chapters on common co-morbidities. The new edition has been completely updated in line
with new British and European Guidelines and contains new chapters on; Natriuretic Peptides and Novel Biomarkers in Heart Failure, The Future of Heart Failure, and Regenerative Therapies.
Essential reading for consultant cardiologists and those in training, general physicians and those caring of the elderly, cardiothoracic surgeons, primary care doctors, pharmacists, and specialist nurses.
Recenzii
The text is comprehensive with detaied physiology but is delivered in a clear and understandable way amd is well supported by an international evidence base. This would be a very useful reference text for anyone involved in the management of complex clinical syndrome.
For the general cardiologist, this textbook provides an important and thorough overview of many aspects of heart failure, and could be a valuable addition to any library. This textook provides a timely, complete, and easy to read reference work for a clinical syndrome that needs a specialized cardiac care.
With the transformation of this field over the past three decades, this book serves as a valuable resource with its wealth of information on topics such as pharmacologic agents, device therapy, mechanical support, transplant, and even end-of-life care. The thorough discussion of the comorbidities which accompany heart failure is unique. This book offers a great review of the field of heart failure.
Notă biografică
Professor Clark was educated at Pembroke College, Cambridge, and trained in medicine at the Westminster Medical School. He trained in cardiology at Manchester Royal Infirmary, the National Heart and Lung Institute (London) and the Western Infirmary, Glasgow.He became a Senior Lecturer in cardiology in the University of Hull in 1999 and was promoted to Reader in 2004 and then Professor in 2009. He is responsible for running the echocardiography service in Hull, and he plays an active role in the day-to-day provision of cardiology services to the population of Hull and the East Riding of Yorkshire.He is Chair of the British Society for Heart Failure, and is a member of the working groups for Heart Failure and Cardiac Rehabilitation and Exercise Physiology in the European Society of Cardiology.Professor Roy Gardner is a Consultant Cardiologist, Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Clydebank, Glasgow. He is also a Honorary Professor University of Glasgow. His research interests include Heart failure, complex devices and biomarkers. Professor Gardner serves on several ESC groups including HF curriculum and HFA examination committees as well as being a scientific advisor/clinical expert to NICETheresa McDonagh is a Consultant Cardiologist at King's College London. Her research interests are in clinical heart failure; in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers.